Neocardial Technologies LLC, based in Minneapolis, MN, is a pioneering company dedicated to addressing the unmet needs of patients suffering from end-stage heart failure. With a mission to provide viable treatment options for this underserved patient group, Neocardial Technologies has developed eHeart, an innovative device designed to offer new hope to those who are no longer responding to standard medical care.
Through their cutting-edge technology and commitment to improving patient outcomes, Neocardial Technologies aims to help individuals with chronic heart failure lead normal, healthy, and long lives. With a focus on research, development, and pre-clinical studies, the company is at the forefront of advancing medical solutions for this critical condition.
Generated from the website
